Effect of Tong Luo Jiu Nao on Aβ-degrading enzymes in AD rat brains

Journal of Ethnopharmacology

Volumn 137, Issue 2, 2011, Pages 1035-1046

  Liu, Yuan ^a   Hua, Qian ^a   Lei, Hongtao ^b   Li, Pengtao ^a  

^a BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

^b INSTITUTE OF CHINESE MATERIA MEDICA   (China)

Author keywords

A ; AD; Insulin degrading enzyme; Neprilysin; Tong Luo Jiu Nao

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[25-35]; CHINESE DRUG; DONEPEZIL; INSULINASE; MEMBRANE METALLOENDOPEPTIDASE; PLANT EXTRACT; SYNAPTOPHYSIN; TONG LUO JIU NAO; UNCLASSIFIED DRUG;

ALTERNATION BEHAVIOR; ALZHEIMER DISEASE; AMYLOID PLAQUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR; BRAIN CORTEX; CELL STRUCTURE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; ENZYME DEGRADATION; HIPPOCAMPAL CA1 REGION; IMMUNOHISTOCHEMISTRY; LEARNING; LEARNING DISORDER; MALE; MAZE TEST; MEMORY DISORDER; NERVE CELL; NEUROPROTECTION; NONHUMAN; PASSIVE AVOIDANCE; PROTEIN DEGRADATION; PROTEIN EXPRESSION; RAT; SHAM PROCEDURE; SPATIAL DISCRIMINATION; SPATIAL MEMORY; SURVIVAL RATE; UPREGULATION; WESTERN BLOTTING;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; AVOIDANCE LEARNING; BRAIN; DISEASE MODELS, ANIMAL; DRUGS, CHINESE HERBAL; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOHISTOCHEMISTRY; INSULYSIN; MALE; MAZE LEARNING; MEMORY; NEPRILYSIN; NEURONS; NEUROPROTECTIVE AGENTS; PEPTIDE FRAGMENTS; RATS; RATS, SPRAGUE-DAWLEY;

ANIMALIA; RATTUS;

EID: 80052023122     PISSN: 03788741     EISSN: 18727573     Source Type: Journal    
DOI: 10.1016/j.jep.2011.07.031     Document Type: Article

References (57)

1. J.A. Affholter, C.L. Hsieh, U. Francke, and R.A. Roth Insulin-degrading enzyme: stable expression of the human complementary DNA, characterization of its protein product, and chromosomal mapping of the human and mouse genes Molecular Endocrinology 4 1990 1125 1135
2. K.A. Bates, G. Verdile, Q.X. Li, D. Ames, P. Hudson, C.L. Masters, and R.N. Martins Clearance mechanisms of Alzheimer's amyloid-beta peptide: implications for therapeutic design and diagnostic tests Molecular Psychiatry 14 2009 469 486
3. R.G. Bennett, W.C. Duckworth, and F.G. Hamel Degradation of amylin by insulin-degrading enzyme Journal of Biological Chemistry 275 2000 36621 36625 (Pubitemid 32002062)
4. E. Buoso, C. Lanni, G. Schettini, S. Govoni, and M. Racchi Beta-amyloid precursor protein metabolism: focus on the functions and degradation of its intracellular domain Pharmacological Research 62 2010 308 317
5. A. Caccamo, S. Oddo, M.C. Sugarman, Y. Akbari, and F.M. LaFerla Age- and region-dependent alterations in Abeta-degrading enzymes: implications for Abeta-induced disorders Neurobiology of Aging 26 2005 645 654 (Pubitemid 40228756)
6. J.A. Carson, and A.J. Turner Beta-amyloid catabolism: roles for neprilysin (NEP) and other metallopeptidases? Journal of Neurochemistry 81 2002 1 8 (Pubitemid 34808849)
7. F. Chen, E.A. Eckman, and C.B. Eckman Reductions in levels of the Alzheimer's amyloid beta peptide after oral administration of ginsenosides FASEB Journal 20 2006 1269 1271
8. Y.F. Cheng, C. Wang, H.B. Lin, Y.F. Li, Y. Huang, J.P. Xu, and H.T. Zhang Inhibition of phosphodiesterase-4 reverses memory deficits produced by Abeta25-35 or Abeta1-40 peptide in rats Psychopharmacology 212 2010 181 191
9. S.J. Choi, M.J. Kim, H.J. Heo, B. Hong, H.Y. Cho, Y.J. Kim, H.K. Kim, S.T. Lim, W.J. Jun, E.K. Kim, and D.H. Shin Ameliorating effect of Gardenia jasminoides extract on amyloid beta peptide-induced neuronal cell deficit Molecules and Cells 24 2007 113 118 (Pubitemid 47554798)
10. J.R Cracchiolo, T. Mori, S.J. Nazian, J. Tan, H. Potter, and G.W. Arendash Enhanced cognitive activity - over and above social or physical activity - is required to protect Alzheimer's mice against cognitive impairment, reduce Abeta deposition, and increase synaptic immunoreactivity Neurobiology of Learning and Memory 88 2007 277 294 (Pubitemid 47321221)
11. R. Deane, R.D. Bell, A. Sagare, and B.V. Zlokovic Clearance of amyloid-beta peptide across the blood-brain barrier: implication for therapies in Alzheimer's disease CNS & Neurological Disorders-Drug Targets 8 2009 16 30
12. V.B. Dorfman, L. Pasquini, M. Riudavets, J.J. Lopez-Costa, A. Villegas, J.C. Troncoso, F. Lopera, E.M. Castano, and L. Morelli Differential cerebral deposition of IDE and NEP in sporadic and familial Alzheimer's disease Neurobiology of Aging 31 2010 1743 1757
13. W.C. Duckworth, R.G. Bennett, and F.G. Hamel A direct inhibitory effect of insulin on a cytosolic proteolytic complex containing insulin-degrading enzyme and multicatalytic proteinase Journal of Biological Chemistry 269 1994 24575 24580 (Pubitemid 24311707)
14. Y.S. Eisele, U. Obermuller, G. Heilbronner, F. Baumann, S.A. Kaeser, H. Wolburg, L.C. Walker, M. Staufenbiel, M. Heikenwalder, and M. Jucker Peripherally applied Abeta-containing inoculates induce cerebral beta-amyloidosis Science 330 2010 980 982
15. S.S. El-Amouri, H. Zhu, J. Yu, R. Marr, I.M. Verma, and M.S. Kindy Neprilysin: an enzyme candidate to slow the progression of Alzheimer's disease American Journal of Pathology 172 2008 1342 1354 (Pubitemid 351671547)
16. W. Farris, S. Mansourian, Y. Chang, L. Lindsley, E.A. Eckman, M.P. Frosch, C.B. Eckman, R.E. Tanzi, D.J. Selkoe, and S. Guenette Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo Proceedings of the National Academy of Sciences of the United States of America 100 2003 4162 4167 (Pubitemid 36418174)
17. W. Farris, S.G. Schutz, J.R. Cirrito, G.M. Shankar, X. Sun, A. George, M.A. Leissring, D.M. Walsh, W.Q. Qiu, D.M. Holtzman, and D.J. Selkoe Loss of neprilysin function promotes amyloid plaque formation and causes cerebral amyloid angiopathy American Journal of Pathology 171 2007 241 251 (Pubitemid 47339241)
18. J. Hardy Amyloid, the presenilins and Alzheimer's disease Trends in Neurosciences 20 1997 154 159 (Pubitemid 27116286)
19. J. Hardy, and D.J. Selkoe The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics Science 297 2002 353 356 (Pubitemid 34790756)
20. J.A. Hardy, and G.A. Higgins Alzheimer's disease: the amyloid cascade hypothesis Science 256 1992 184 185
21. E. Hellstrom-Lindahl, R. Ravid, and A. Nordberg Age-dependent decline of neprilysin in Alzheimer's disease and normal brain: inverse correlation with A beta levels Neurobiology of Aging 29 2008 210 221
22. L.B. Hersh Degradation of enkephalins: the search for an enkephalinase Molecular and Cellular Biochemistry 47 1982 35 43 (Pubitemid 13232773)
23. L.B Hersh, and D.W. Rodgers Neprilysin and amyloid beta peptide degradation Current Alzheimer Research 5 2008 225 231 (Pubitemid 351536347)
24. L. Holcomb, M.N. Gordon, E. McGowan, X. Yu, S. Benkovic, P. Jantzen, K. Wright, I. Saad, R. Mueller, D. Morgan, S. Sanders, C. Zehr, K. O'Campo, J. Hardy, C.M. Prada, C. Eckman, S. Younkin, K. Hsiao, and K. Duff Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes Nature Medicine 4 1998 97 100 (Pubitemid 28133087)
25. K. Hsiao, P. Chapman, S. Nilsen, C. Eckman, Y. Harigaya, S. Younkin, F. Yang, and G. Cole Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice Science 274 1996 99 102 (Pubitemid 26332733)
26. Q. Hua, X. Qing, P. Li, W. Li, J. Hou, J. Hu, Q. Hong, P. Sun, and X. Zhu Brain microvascular endothelial cells mediate neuroprotective effects on ischemia/reperfusion neurons Journal of Ethnopharmacology 129 2010 306 313
27. B.T. Hyman, G.W. Van Hoesen, A.R. Damasio, and C.L. Barnes Alzheimer's disease: cell-specific pathology isolates the hippocampal formation Science 225 1984 1168 1170 (Pubitemid 14029099)
28. N. Iwata, M. Higuchi, and T.C. Saido Metabolism of amyloid-beta peptide and Alzheimer's disease Pharmacology and Therapeutics 108 2005 129 148 (Pubitemid 41527082)
29. N. Iwata, S. Tsubuki, Y. Takaki, K. Shirotani, B. Lu, N.P. Gerard, C. Gerard, E. Hama, H.J. Lee, and T.C. Saido Metabolic regulation of brain Abeta by neprilysin Science 292 2001 1550 1552 (Pubitemid 32493424)
30. N. Iwata, S. Tsubuki, Y. Takaki, K. Watanabe, M. Sekiguchi, E. Hosoki, M. Kawashima-Morishima, H.J. Lee, E. Hama, Y. Sekine-Aizawa, and T.C. Saido Identification of the major Abeta1-42-degrading catabolic pathway in brain parenchyma: suppression leads to biochemical and pathological deposition Nature Medicine 6 2000 143 150 (Pubitemid 30082357)
31. R.P. Jaya Prasanthi, E. Schommer, S. Thomasson, A. Thompson, G. Feist, and O. Ghribi Regulation of beta-amyloid levels in the brain of cholesterol-fed rabbit, a model system for sporadic Alzheimer's disease Mechanisms of Ageing and Development 129 2008 649 655
32. S. Kasturirangan, and M. Sierks Targeted hydrolysis of Beta-amyloid with engineered antibody fragment Current Alzheimer Research 7 2010 214 222
33. W.E. Klunk, R.F. Jacob, and R.P. Mason Quantifying amyloid beta-peptide (Abeta) aggregation using the Congo red-Abeta (CR-abeta) spectrophotometric assay Analytical Biochemistry 266 1999 66 76 (Pubitemid 29024609)
34. I.V. Kurochkin, and S. Goto Alzheimer's beta-amyloid peptide specifically interacts with and is degraded by insulin degrading enzyme FEBS Letters 345 1994 33 37
35. S.H. Kwon, H.K. Lee, J.A. Kim, S.I. Hong, S.Y. Kim, T.H. Jo, Y.I. Park, C.K. Lee, Y.B. Kim, S.Y. Lee, and C.G. Jang Neuroprotective effects of Eucommia ulmoides Oliv. bark on amyloid beta(25-35)-induced learning and memory impairments in mice Neuroscience Letters 487 2011 123 127
36. Y. Liu, C. Studzinski, T. Beckett, M.P. Murphy, R.L. Klein, and L.B. Hersh Circulating neprilysin clears brain amyloid Molecular and Cellular Neurosciences 45 2010 101 107
37. P. Marambaud, H. Zhao, and P. Davies Resveratrol promotes clearance of Alzheimer's disease amyloid-beta peptides Journal of Biological Chemistry 280 2005 37377 37382 (Pubitemid 41642343)
38. R.A. Marr, H. Guan, E. Rockenstein, M. Kindy, F.H. Gage, I. Verma, E. Masliah, and L.B. Hersh Neprilysin regulates amyloid Beta peptide levels Journal of Molecular Neuroscience 22 2004 5 11 (Pubitemid 41359010)
39. T. Maurice, J.L. Junien, and A. Privat Dehydroepiandrosterone sulfate attenuates dizocilpine-induced learning impairment in mice via sigma 1-receptors Behavioural Brain Research 83 1997 159 164 (Pubitemid 27086630)
40. T. Maurice, B.P. Lockhart, and A. Privat Amnesia induced in mice by centrally administered beta-amyloid peptides involves cholinergic dysfunction Brain Research 706 1996 181 193 (Pubitemid 26048681)
41. J.R. McDermott, and A.M. Gibson Degradation of Alzheimer's beta-amyloid protein by human and rat brain peptidases: involvement of insulin-degrading enzyme Neurochemical Research 22 1997 49 56
42. J.S. Miners, S. Baig, J. Palmer, L.E. Palmer, P.G. Kehoe, and S. Love Abeta-degrading enzymes in Alzheimer's disease Brain Pathology 18 2008 240 252
43. J.S. Miners, S. Baig, H. Tayler, P.G. Kehoe, and S. Love Neprilysin and insulin-degrading enzyme levels are increased in Alzheimer disease in relation to disease severity Journal of Neuropathology and Experimental Neurology 68 2009 902 914
44. J.S. Miners, Z. van Helmond, P.G. Kehoe, and S. Love Changes with age in the activities of beta-secretase and the Abeta-degrading enzymes neprilysin, insulin-degrading enzyme and angiotensin-converting enzyme Brain Pathology 20 2010 794 802
45. R.I. Misbin, and E.C. Almira Degradation of insulin and insulin-like growth factors by enzyme purified from human erythrocytes. Comparison of degradation products observed with A14- and B26-[125I] monoiodoinsulin Diabetes 38 1989 152 158 (Pubitemid 19054794)
46. W.Q. Qiu, and M.F. Folstein Insulin, insulin-degrading enzyme and amyloid-beta peptide in Alzheimer's disease: review and hypothesis Neurobiology of Aging 27 2006 190 198 (Pubitemid 43038542)
47. W.Q. Qiu, D.M. Walsh, Z. Ye, K. Vekrellis, J. Zhang, M.B. Podlisny, M.R. Rosner, A. Safavi, L.B. Hersh, and D.J. Selkoe Insulin-degrading enzyme regulates extracellular levels of amyloid beta-protein by degradation Journal of Biological Chemistry 273 1998 32730 32738 (Pubitemid 28557658)
48. T.T. Rohn, V. Vyas, T. Hernandez-Estrada, K.E. Nichol, L.A. Christie, and E. Head Lack of pathology in a triple transgenic mouse model of Alzheimer's disease after overexpression of the anti-apoptotic protein Bcl-2 Journal of Neuroscience 28 2008 3051 3059 (Pubitemid 351442294)
49. C. Schmitz, B.P. Rutten, A. Pielen, S. Schafer, O. Wirths, G. Tremp, C. Czech, V. Blanchard, G. Multhaup, P. Rezaie, H. Korr, H.W. Steinbusch, L. Pradier, and T.A. Bayer Hippocampal neuron loss exceeds amyloid plaque load in a transgenic mouse model of Alzheimer's disease American Journal of Pathology 164 2004 1495 1502 (Pubitemid 38387814)
50. K. Van der Borght, R. Havekes, T. Bos, B.J. Eggen, and E.A. Van der Zee Exercise improves memory acquisition and retrieval in the Y-maze task: relationship with hippocampal neurogenesis Behavioral Neuroscience 121 2007 324 334 (Pubitemid 47445083)
51. S. Vepsalainen, S. Helisalmi, A. Mannermaa, T. Pirttila, H. Soininen, and M. Hiltunen Combined risk effects of IDE and NEP gene variants on Alzheimer disease Journal of Neurology, Neurosurgery and Psychiatry 80 2009 1268 1270
52. T.C. Wheeler, L.S. Chin, Y. Li, F.L. Roudabush, and L. Li Regulation of synaptophysin degradation by mammalian homologues of seven in absentia Journal of Biological Chemistry 277 2002 10273 10282 (Pubitemid 34968143)
53. O.L. Wolthuis Behavioural effects of etiracetam in rats Pharmacology, Biochemistry and Behavior 15 1981 247 255
54. L. Yang, J. Hao, J. Zhang, W. Xia, X. Dong, X. Hu, F. Kong, and X. Cui Ginsenoside Rg3 promotes beta-amyloid peptide degradation by enhancing gene expression of neprilysin Journal of Pharmacy and Pharmacology 61 2009 375 380
55. T. Yoshida, K. Ohno-Matsui, S. Ichinose, T. Sato, N. Iwata, T.C. Saido, T. Hisatomi, M. Mochizuki, and I. Morita The potential role of amyloid beta in the pathogenesis of age-related macular degeneration Journal of Clinical Investigation 115 2005 2793 2800 (Pubitemid 41434406)
56. X.J. Zhang, Y.C. Niu, L. Zhou, and P.T. Li Expression of BACE1 mRNA in Aβ1-40 induced AD in rats and the effect of TLJN Oral Solution Pharmacology and Clinics of Chinese Materia Medica 22 2006 50 53
57. X.J Zhang, Y.C. Niu, G.H. Xing, C.R. Lin, X.Y. Li, and P.T. Li Effect of Tongluo Jiunao oral solution on learning and memory and the expression of AChE in hippocampus of AD rats China Journal of TCM and Pharmacy 22 2007 410 413